Skip to content

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

iCCARE Project # 4: Grounded Theory Study of the Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men Diagnosed With Prostate Cancer

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06472817
Enrollment
80
Registered
2024-06-25
Start date
2023-09-05
Completion date
2026-09-11
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Carcinoma

Brief summary

This study is being done to understand what social factors affect health decisions for those who have immigrated from another country by examining how the immigration from Sub-Sahara Africa affects the experiences of participants regarding health-seeking behaviors, care, and treatment of prostate cancer. It also examines similarities and differences among participants based on their region of origin in Africa.

Detailed description

PRIMARY OBJECTIVE: I. To employ the social determinant of migrant health framework (International Organization for Migration, n.d.) to examine the impact of immigration on the health-seeking behaviors of SSAI including informed-decision making, psychosocial effects and coping mechanisms. (Phase I) II. To examine SDOMH factors among SSAI and CI men, including their migration experience and health behaviors. (Phase II) OUTLINE: This is an observational study. AIM I: Participants complete a survey and participate in an interview in person, over the phone, or via zoom on study. AIM II: Participants complete an interview in person, over the phone, or via zoom on study.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Sponsors

Mayo Clinic
Lead SponsorOTHER
Congressionally Directed Medical Research Programs
CollaboratorFED

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* PHASE I: * Adult men originally from each of these geographic regions (East, West, Central, and Southern Africa) and have been diagnosed with prostate cancer * Able to provide written consent and conduct an interview * Able to speak and understand English * PHASE II: * Caribbean Immigrant men and SSAI men diagnosed with CaP within the last 10 years who identify as Black and speak English * Able to provide written consent and conduct an interview * Able to speak and understand English

Exclusion criteria

* PHASE I: * Patients below the ages of 18, and those not belonging to any of four regions * Employees of Mayo Clinic will be excluded * Non-English speakers will not be included * PHASE II: * Individuals below the age of 18 * Those not diagnosed with prostate cancer and individuals not from the regions described above * Employees of Mayo Clinic will be excluded * Non-English speakers will not be included

Design outcomes

Primary

MeasureTime frameDescription
Qualitative Interview - identification of themes and constructsBaselineData will be collected during an in-depth interview and will be analyzed with an inductive, open coding approach, first identifying themes, then constructs that emerge from the data will be categorized and mapped, noting new concepts and constructs. Theme convergence and divergence will be assessed. The interview guide focuses on participants' experiences and health-seeking behaviors regarding prostate cancer prevention, detection, decision-making, treatment, care, and survivorship.
Immigrant social determinants of health factors that impact Sub-Saharan African Immigrant (SSAI) carcinoma of the prostate (CaP) survivorsBaselineFrom the data generated in Outcome 1 interviews, an interpretive framework or theoretical model for SSAI men will be developed to evaluate and identify factors that contribute to or exacerbate disparities in prostate cancer.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORGladys B. Asiedu, Ph.D.

Mayo Clinic in Rochester

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026